Cerity Partners LLC increased its Biogen stake by 76.7%, acquiring 35,696 additional shares to hold 82,248 shares worth $11.5 million after Q3 activity. Biogen also reported Q3 earnings of $4.81 per share on $2.53 billion revenue, beating consensus by $0.92 with revenue up 2.8% year-over-year.